Keyphrases
Anti-PD-1
25%
Anti-PD-1 Therapy
25%
Biomarkers of Response
25%
Bona Fide
25%
Carcinoma Cell Lines
25%
Cell Line Models
25%
Checkpoint Blockade
100%
Combination Therapeutics
25%
Combination Therapy
25%
ELISPOT
25%
H-2Kb
25%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
75%
Hematopoietic Cells
25%
Immunogenomics
100%
Immunotherapy Targets
25%
Infiltrating T Cells
25%
Infiltration
25%
Lymphocytes
25%
MOC2
25%
Murine Model
100%
Mutation Burden
50%
Neoantigen
100%
Novel Therapeutics
25%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
100%
Potential Biomarkers
25%
Squamous Carcinoma Cells
25%
Subcellular Transcriptomics
25%
Syngeneic
25%
T Cell Subpopulations
25%
Targeted Therapy
25%
Tetramer Analysis
25%
Therapeutic Vaccine
25%
Tumor
50%
Tumor Development
25%
Tumor Neoantigens
25%
Tumor-draining Lymph Nodes
25%
Vaccination
25%
Immunology and Microbiology
Cell Population
20%
ELISPOT
20%
Head and Neck Squamous Cell Carcinoma Cell Line
20%
Hematopoietic Cell
20%
Immunotherapy
40%
Lymph Node
20%
Lymphocyte
20%
Neck
40%
Neoantigen
100%
Squamous Cell
100%
Syngenic
20%
T Cell
20%
Transcriptomics
20%